Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease: A REVIEW OF CURRENT EXPERIENCE AND PRACTICE-BASED RECOMMENDATIONS.
Journal
Journal of cardiopulmonary rehabilitation and prevention
ISSN: 1932-751X
Titre abrégé: J Cardiopulm Rehabil Prev
Pays: United States
ID NLM: 101291247
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
pubmed:
18
9
2022
medline:
31
12
2022
entrez:
17
9
2022
Statut:
ppublish
Résumé
This review encompasses several practical components of supervised exercise therapy (SET) for patients with claudication including referral, exercise training, and billing issues. Real-life SET session examples are also provided. SET was approved for reimbursement by the Centers for Medicare & Medicaid Services (CMS) in 2017, and there is continual growth of programs offering SET and in participation. The purpose of this review is to provide useful information for the clinical exercise professionals working with these patients. The 2016 ACC/AHA Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (PAD) provided a class I (highest level) recommendation for the use of SET in those with symptomatic PAD. Since there has been much growth in the literature about the utility of SET, the literature was reviewed (PubMed) to provide information for this article. Topics reviewed include the benefits of exercise training, exercise prescription, billing, referral and participation, and best practices. SET should be offered to all patients with symptomatic PAD who are not at risk of acute limb ischemia. For optimal results, SET should be implemented several times per week and in a progressive process to increase exercise intensity as tolerated. For best results, programs should recommend patients supplement SET with home exercise. Considerations for utilizing reimbursed sessions should also be discussed because patients have a maximum of 72 sessions/lifetime. Referral practices need refinement, and participation rates remain extremely low and may be influenced by demographics. Research on best practices and home or hybrid training must continue to address issues related to common enrollment and participation barriers. Supervised exercise training (SET) for symptomatic peripheral artery disease is a class IA recommendation and reimbursable by most insurances. Improvements in walking performance can be dramatic. However, referral and participation in SET remain very low and thus SET is vastly underutilized.
Identifiants
pubmed: 36114638
doi: 10.1097/HCR.0000000000000723
pii: 01273116-202301000-00003
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15-21Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Hageman D, Fokkenrood HJ, Gommans LN, van den Houten MM, Teijink JA. Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev. 2018;4(4):CD005263. doi:10.1002/14651858.CD005263.pub4.
Saratzis A, Paraskevopoulos I, Patel S, et al. Supervised exercise therapy and revascularization for intermittent claudication: network meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2019;12(12):1125–1136.
Biswas MP, Capell WH, McDermott MM, et al. Exercise training and revascularization in the management of symptomatic peripheral artery disease. JACC Basic Transl Sci. 2021;6(2):174–188.
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):e71–e126. doi:10.1016/j.jacc.2016.11.007. Erratum in: J Am Coll Cardiol. 2017;69(11):1521.
Medicare National Coverage Determination Manual. 20.35: Supervised exercise therapy (SET) for symptomatic peripheral artery disease (PAD). https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=371&ncdver=1 . Published May 25, 2017. Accessed April 27, 2022.
Dua A, Gologorsky R, Savage D, et al. National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication. J Vasc Surg. 2020;71(5):1702–1707.
Dieter RS, Chu WW, Pacanowski JP Jr, McBride PE, Tanke TE. The significance of lower extremity peripheral arterial disease. Clin Cardiol. 2002;25:3–10.
Gardner AW, Montgomery PS, Wang M, et al. Daily step counts in participants with and without peripheral artery disease. J Cardiopulm Rehabil Prev. 2021;41(3):182–187.
Treat-Jacobson D, McDermott MM, Bronas UG, et al. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(4):e10–e33. doi:10.1161/CIR.0000000000000623.
Treat-Jacobson D, McDermott MM, Beckman JA, et al. Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association. Circulation. 2019;140(13):e700–e710.
Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347(24):1941–1951.
Andreozzi G, Leone A, Laudani R, Deinite G, Martini R. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication and its improvement after supervised physical training. Int Angiol. 2007;26(1):12–17.
Duscha BD, Robbins JL, Jones WS, et al. Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol. 2011;31(11):2742–2748.
Hiatt W, Regensteiner J, Wolfel E, Carry M, Brass E. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. 1996;81:780–788.
Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg. 1997;14(5):344–350.
Womack CJ, Sieminski DJ, Katzel LI, Yataco A, Gardner AW. Improved walking economy in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc. 1997;29(10):1286–1290.
Gardner AW, Montgomery PS, Wang M, Shen B. Association between daily steps at moderate cadence and vascular outcomes in patients with claudication. J Cardiopulm Rehabil Prev. 2022;42(1):52–58.
Gardner AW, Montgomery PS, Wang M, Shen B, Zhang S, Pomilla WA. Association between meeting physical activity time-intensity guidelines with ambulation, quality of life, and inflammation in claudication. J Cardiopulm Rehabil Prev. 2022;42(6):E82–E89. doi:10.1097/HCR.0000000000000686.
Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009;14(3):203–213.
Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12(12):CD000990. doi:10.1002/14651858.CD000990.pub4.
Bronas UG, Treat-Jacobson D, Leon AS. Comparison of the effect of upper body-ergometry aerobic training vs treadmill training on central cardiorespiratory improvement and walking distance in patients with claudication. J Vasc Surg. 2011;53(6):1557–1564.
Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis. 2011;218(1):1–12.
Salisbury DL, Swanson K, Brown RJ, Treat-Jacobson D. Total body recumbent stepping vs treadmill walking in supervised exercise therapy: a pilot study. Vasc Med. 2022;27(2):150–157.
Gardner AW, Montgomery PS, Parker DE. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg. 2008;47(1):117–122.
Gardner AW, Addison O, Katzel LI, et al. Association between physical activity and mortality in patients with claudication. Med Sci Sports Exerc. 2021;53(4):732–739.
McDermott MM, Greenland P, Tian L, et al. Association of 6-minute walk performance and physical activity with incident ischemic heart disease events and stroke in peripheral artery disease. J Am Heart Assoc. 2015;4(7):e001846. doi:10.1161/JAHA.115.001846.
Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–2028.
Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2014;3(5):e001107. doi:10.1161/JAHA.114.001107.
Salisbury DL, Whipple MO, Burt M, et al. Experience implementing supervised exercise therapy for peripheral artery disease. J Clin Exerc Physiol. 2019;8(1):1–12. doi:10.31189/2165-6193-8.1.1.
Pub 100-04 Medicare Claims Processing Manual. Change Request 11022, Transmittal 4229. https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2019Downloads/R4229CP.pdf . Published February 1, 2019. Accessed April 27, 2022.
MLN Matters 11022: SET for PAD-Clarification of Payment Rules and Expansion of International Classification of Diseases (ICD-10) Diagnosis Codes. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM11022.pdf . Published February 1, 2019. Accessed April 27, 2022.
Vart P, Coresh J, Kwak L, Ballew SH, Heiss G, Matsushita K. Socioeconomic status and incidence of hospitalization with lower-extremity peripheral artery disease: atherosclerosis risk in communities study. J Am Heart Assoc. 2017;6(8):e004995. doi:10.1161/JAHA.116.004995.
Divakaran S, Carroll BJ, Chen S, Shen C, Bonaca MP, Secemsky EA. Supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries between 2017 and 2018: participation rates and outcomes [published online ahead of print July 23, 2021]. Circ Cardiovasc Qual Outcomes. 2021;14(8):e007953. doi:10.1161/CIRCOUTCOMES.121.007953.
Centers for Medicare & Medicaid Services. License for Use of Current Procedural Terminology, Fourth Edition (“CPT®”). Baltimore, MD: Centers for Medicare & Medicaid Services; 169 and 175. https://www.cms.gov/license/ama?file=/files/zip/2022-nprm-opps-data-addendum-b-and-2-times-rule.zip . Published 2022. Accessed April 27, 2022.